Literature DB >> 19021270

Assessment of urinary total testosterone production by a highly sensitive time-resolved fluorescence immunoassay.

Shihua Bao1, Yifeng Peng, Shile Sheng, Qide Lin.   

Abstract

Radioimmunoassay (RIA) that involves purification of the analyte by organic solvent extraction is widely used. Although the extraction RIA is reliable when properly validated, it is time consuming and radioactive, we measure urinary total testosterone with a highly sensitive rapid and accurate time-resolved fluorescence immunoassay (TRFIA) method. High affinity antitestosterone antibody and Eu(3+) labeled Donkey antisheep IgG as tracers were used. The assay was evaluated for specificity, sensitivity, analytical recovery, precision and dilution linearity by the TRFIA method on urine samples. A satisfactory standard curve for testosterone TRFIA has been developed with good sensitivity (5.1 pmol/L). The validity of the assay for urinarytotal testosterone was confirmed by the good correlation between the results obtained by TRFIA (X) and those RIA (Y) (Y=0.075+0.971X, R=0.992). Specificity, analytical recovery, precision and dilution linearity studies were determined and all found to be satisfactory. Male urinary total testosterone excretion ranged from 64.00 to 374.11 nmol/24 hr, which was about four times more than the range for women urinary testosterone excretion (14.16-100.65 nmol/24 hr), which suggests that a direct, reliable, easy to automate, highly sensitive and specific TRFIA type assay for the measurement of total testosterone in urine samples has been developed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19021270      PMCID: PMC6649076          DOI: 10.1002/jcla.20283

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  22 in total

1.  Cortisol and free thyroxine determination by time-resolved fluorometry in canine serum.

Authors:  M D Parra; L J Bernal; J J Cerón
Journal:  Can J Vet Res       Date:  2004-04       Impact factor: 1.310

2.  Diurnal rhythms of luteinizing hormone, follicle-stimulating hormone, and testosterone secretion before the onset of male puberty.

Authors:  R Mitamura; K Yano; N Suzuki; Y Ito; Y Makita; A Okuno
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958

3.  Time-resolved fluorometer for lanthanide chelates--a new generation of nonisotopic immunoassays.

Authors:  E Soini; H Kojola
Journal:  Clin Chem       Date:  1983-01       Impact factor: 8.327

4.  Immunofluorometry of choriogonadotropin by time-resolved fluorescence spectroscopy, with a new europium chelate as label.

Authors:  M J Khosravi; E P Diamandis
Journal:  Clin Chem       Date:  1987-11       Impact factor: 8.327

5.  Development of time-resolved immunofluorometric assays for CA 72-4 and application in sera of patients with gastric tumors.

Authors:  Shi Le Sheng; Qing Wang; Gang Huang
Journal:  Clin Chim Acta       Date:  2007-01-30       Impact factor: 3.786

6.  Development of a highly sensitive and specific new testosterone time-resolved fluoroimmunoassay in human serum.

Authors:  Jean Fiet; Frank Giton; Ibrahim Fidaa; Alain Valleix; Hervé Galons; Jean-Pierre Raynaud
Journal:  Steroids       Date:  2004-07       Impact factor: 2.668

7.  Effects of chrysin on urinary testosterone levels in human males.

Authors:  Cristiana Gambelunghe; Ruggero Rossi; Marco Sommavilla; Chiara Ferranti; Riccardo Rossi; Chiara Ciculi; Stefania Gizzi; Alessandra Micheletti; Stefano Rufini
Journal:  J Med Food       Date:  2003       Impact factor: 2.786

8.  Urinary profile of androgen metabolites in a population of sportswomen during the menstrual cycle.

Authors:  V A Bricout; F Wright; M Lagoguey
Journal:  Int J Sports Med       Date:  2003-04       Impact factor: 3.118

9.  Detection of hepatitis B surface antigen using time-resolved fluoroimmunoassay.

Authors:  H Siitari; I Hemmilä; E Soini; T Lövgren; V Koistinen
Journal:  Nature       Date:  1983-01-20       Impact factor: 49.962

10.  Urinary endogenous sex hormone levels and the risk of postmenopausal breast cancer.

Authors:  N C Onland-Moret; R Kaaks; P A H van Noord; S Rinaldi; T Key; D E Grobbee; P H M Peeters
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.